Deutsche Bank’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-121
Closed -$71K 4269
2022
Q1
$71K Buy
121
+17
+16% +$12.6K ﹤0.01% 3709
2021
Q4
$115K Buy
104
+5
+5% +$10.9K ﹤0.01% 3644
2021
Q3
$380K Sell
99
-25
-20% -$78.8K ﹤0.01% 3211
2021
Q2
$357K Buy
124
+37
+43% +$87.4K ﹤0.01% 3447
2021
Q1
$175K Buy
87
+30
+53% +$45.1K ﹤0.01% 3707
2020
Q4
$54K Buy
57
+16
+39% +$13.7K ﹤0.01% 4098
2020
Q3
$32K Buy
41
+4
+11% +$3.56K ﹤0.01% 4036
2020
Q2
$35K Buy
+37
New +$37K ﹤0.01% 3950
2018
Q1
Sell
-11
Closed -$11K 5547
2017
Q4
$11K Buy
11
+3
+38% +$5.28K ﹤0.01% 4761
2017
Q3
$20K Buy
8
+4
+100% +$8.28K ﹤0.01% 4565
2017
Q2
$7K Buy
+4
New +$8.28K ﹤0.01% 4708

Other funds holding PAVM

Deutsche Bank's PAVM Position: Q2 2022 in Review

Deutsche Bank sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 121 shares — an estimated $71K sold.

Deutsche Bank first reported a position in PAVM in Q2 2017 and held it in 11 quarters. The position peaked at $380K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • Deutsche Bank reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 121 PAVmed shares in Q2 2022, an estimated $71K.
  • Deutsche Bank first reported a position in PAVmed in Q2 2017 and held it in 11 quarters.
  • Deutsche Bank's PAVmed position peaked at $380K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.